Financials Guardant Health, Inc.

Equities

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-06 pm EST			5-day change	1st Jan Change
91.20 ^USD	-1.49%		-2.88%	-10.71%

Mar. 05	Guardant Health Insider Sold Shares Worth $3,812,661, According to a Recent SEC Filing	MT
Mar. 04	Guardant Health Launches Coast-To-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to over 100 Communities Across America	CI

Projected Income Statement: Guardant Health, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	373.7	449.5	563.9	739	982	1,272	1,636	2,083
Change	-	20.31%	25.45%	31.04%	32.88%	29.54%	28.6%	27.34%
EBITDA ¹	-388.7	-498.9	-436.3	-399.5	-220.8	-168.4	-14.19	197.3
Change	-	-28.34%	12.55%	8.42%	44.72%	23.74%	91.57%	1,490.18%
EBIT ¹	-411	-544.4	-564.7	-443.6	-437.2	-383.1	-268.3	-41.98
Change	-	-32.45%	-3.74%	21.45%	1.43%	12.38%	29.96%	84.35%
Interest Paid ¹	-2.577	-2.577	-2.578	-2.581	-3.897	-4.111	-4.09	-3.699
Earnings before Tax (EBT) ¹	-384.5	-653.4	-478.8	-435.1	-417.5	-382.6	-279.5	-70.6
Change	-	-69.96%	26.73%	9.12%	4.03%	8.37%	26.95%	74.74%
Net income ¹	-405.7	-654.6	-479.4	-436.4	-416.3	-379.8	-266.1	-51.83
Change	-	-61.36%	26.76%	8.98%	4.61%	8.75%	29.94%	80.52%
Announcement Date	2/23/22	2/23/23	2/22/24	2/20/25	2/19/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	78.66	92.1	94.78	108.1	96.1	109.1	117.4	126.9	128.7	137.2	143	155.1	168.5	177.2	191.5	201.8	203.5	232.1	265.2	281.3	279.7	306	332.5	354.1	362	394.6	424	451.3
Change	-	17.08%	2.91%	14.06%	-11.11%	13.57%	7.57%	8.08%	1.44%	6.55%	4.29%	8.41%	8.67%	5.19%	8.04%	5.4%	0.82%	14.06%	14.27%	6.06%	-0.55%	9.41%	8.64%	6.51%	2.22%	9.01%	7.45%	6.43%
EBITDA ¹	-102.9	-92.02	-101.7	-92.12	-111.6	-120	-122.6	-133.3	-123.4	-108.1	-101.8	-102.9	-88.48	-89.58	-106.2	-115.3	-97.78	-95.49	-45.5	-64.91	-49.67	-43.28	-34.48	-41.07	-	-	-	-
Change	-	10.54%	-10.57%	9.46%	-21.11%	-7.57%	-2.18%	-8.68%	7.37%	12.39%	5.91%	-1.14%	14.03%	-1.25%	-18.55%	-8.53%	15.17%	2.34%	52.35%	-42.65%	23.48%	12.87%	20.32%	-19.09%	-	-	-	-
EBIT ¹	-107.9	-97.64	-107.3	-98.21	-123.3	-130.3	-144.6	-146.1	-134.1	-119.6	-113.5	-197.5	-99.68	-100.6	-117.3	-126	-111	-106.4	-98.99	-120.8	-103.6	-98.68	-90.41	-88.12	-78.33	-68.75	-54.25	-47.54
Change	-	9.48%	-9.88%	8.46%	-25.59%	-5.66%	-10.96%	-1.05%	8.26%	10.77%	5.08%	-73.95%	49.53%	-0.94%	-16.61%	-7.36%	11.85%	4.17%	6.98%	-22.04%	14.22%	4.76%	8.38%	2.53%	11.11%	12.23%	21.09%	12.36%
Charge d'intérêts ¹	-0.646	-0.644	-0.644	-0.643	-0.644	-0.645	-0.644	-0.644	-0.644	-0.645	-0.644	-0.645	-0.645	-0.645	-0.646	-0.645	-0.791	-0.983	-0.943	-1.18	-1.043	-1.036	-1.043	-1.036	-1.079	-1.063	-1.079	-1.039
Earnings before Tax (EBT) ¹	-107.2	-97.49	-107.4	-72.3	-123.3	-229	-161.9	-139.3	-133.3	-72.28	-85.61	-187.6	-114.6	-102.5	-107.7	-110.3	-94.87	-99.86	-92.59	-130.2	-104.9	-98.04	-89.56	-87.15	-83.04	-71.91	-56.89	-53.26
Change	-	9.1%	-10.19%	32.7%	-70.47%	-85.79%	29.31%	13.93%	4.33%	45.78%	-18.45%	-119.11%	38.92%	10.55%	-5.1%	-2.38%	13.98%	-5.26%	7.28%	-40.64%	19.46%	6.52%	8.66%	2.69%	4.71%	13.4%	20.9%	6.38%
Net income ¹	-109.7	-97.58	-107.5	-90.91	-123.2	-229.4	-162	-139.9	-133.5	-72.77	-86.1	-187	-115	-102.6	-107.8	-111	-95.16	-99.9	-92.72	-128.5	-102.5	-97.54	-88.17	-91.9	-82.56	-70.91	-53.1	-46.85
Change	-	11.02%	-10.2%	15.45%	-35.55%	-86.18%	29.39%	13.62%	4.57%	45.5%	-18.32%	-117.23%	38.52%	10.75%	-4.99%	-3.02%	14.28%	-4.98%	7.18%	-38.58%	20.22%	4.85%	9.61%	-4.23%	10.17%	14.11%	25.11%	11.77%
Announcement Date	5/6/21	8/5/21	11/4/21	2/23/22	5/5/22	8/4/22	11/3/22	2/23/23	5/9/23	8/3/23	11/6/23	2/22/24	5/9/24	8/7/24	11/6/24	2/20/25	4/30/25	7/30/25	10/29/25	2/19/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Guardant Health, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	202	126	-28.7	303	302	411	509	331
Change	-	-37.62%	-122.78%	1,155.75%	-0.33%	35.91%	23.84%	-34.97%
Announcement Date	2/23/22	2/23/23	2/22/24	2/20/25	2/19/26	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Guardant Health, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	75.04	77.46	20.49	35.08	48.31	50.75	52.06	66.95
Change	-	3.23%	-73.55%	71.26%	37.68%	5.05%	2.6%	28.6%
Free Cash Flow (FCF) ¹	-284.1	-386.9	-345.5	-274.9	-233.1	-235.6	-127.5	110
Change	-	-36.22%	10.72%	20.41%	15.23%	-1.09%	45.88%	186.25%
Announcement Date	2/23/22	2/23/23	2/22/24	2/20/25	2/19/26	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Guardant Health, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-104.04%	-110.98%	-77.36%	-54.06%	-22.49%	-13.24%	-0.87%	9.47%
EBIT Margin (%)	-110%	-121.1%	-100.14%	-60.02%	-44.53%	-30.12%	-16.4%	-2.02%
EBT Margin (%)	-102.89%	-145.36%	-84.9%	-58.87%	-42.52%	-30.08%	-17.08%	-3.39%
Net margin (%)	-108.57%	-145.61%	-85.02%	-59.05%	-42.39%	-29.86%	-16.27%	-2.49%
FCF margin (%)	-76.02%	-86.07%	-61.26%	-37.2%	-23.73%	-18.52%	-7.79%	5.28%
FCF / Net Income (%)	70.02%	59.11%	72.05%	63.01%	55.99%	62.03%	47.91%	-212.15%
Profitability
ROA	-18.13%	-34.32%	-28.23%	-26.67%	-13.04%	-19.33%	-10.23%	6.65%
ROE	-41.75%	-185.65%	-438.12%	-	-	-150.64%	-18.01%	28.64%
Financial Health
Leverage (Debt/EBITDA)	-0.52x	-0.25x	-	-0.76x	-1.37x	-2.44x	-35.88x	1.68x
Debt / Free cash flow	-0.71x	-0.33x	-	-1.1x	-1.3x	-1.74x	-3.99x	3.01x
Capital Intensity
CAPEX / Current Assets (%)	20.08%	17.23%	3.63%	4.75%	4.92%	3.99%	3.18%	3.21%
CAPEX / EBITDA (%)	-19.3%	-15.53%	-4.7%	-8.78%	-21.87%	-30.13%	-366.81%	33.93%
CAPEX / FCF (%)	-26.42%	-20.02%	-5.93%	-12.76%	-20.73%	-21.54%	-40.83%	60.88%
Items per share
Cash flow per share ¹	-2.063	-3.029	-2.902	-1.954	-1.474	-0.9858	-0.2924	-
Change	-	-46.8%	4.19%	32.66%	24.58%	33.11%	70.34%	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	6.338	0.5864	1.305	-1.126	-0.7602	-2.608	-1.174	0.9905
Change	-	-90.75%	122.46%	-186.33%	32.5%	-243.06%	54.99%	184.38%
EPS ¹	-4	-6.41	-4.28	-3.56	-3.32	-2.947	-2.116	-0.4807
Change	-	-60.25%	33.23%	16.82%	6.74%	11.25%	28.17%	77.28%
Nbr of stocks (in thousands)	101,656	102,436	121,380	123,555	128,839	131,170	131,170	131,170
Announcement Date	2/23/22	2/23/23	2/22/24	2/20/25	2/19/26	-	-	-